An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone.
Lee KC, Sud S, Meyer CR, Moffat BA, Chenevert TL, Rehemtulla A, Pienta KJ, Ross BD. An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res. 2007 Apr 15; 67(8):3524-8.